Mind Medicine (MindMed) Inc.
MNMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $1 | $3 | $0 | $0 |
| Gross Profit | -$1 | -$3 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $65 | $49 | $36 | $35 |
| G&A Expenses | $39 | $42 | $30 | $59 |
| SG&A Expenses | $39 | $42 | $30 | $59 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$1 | $0 | $0 | $0 |
| Operating Expenses | $103 | $91 | $66 | $94 |
| Operating Income | -$104 | -$94 | -$66 | -$94 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$5 | -$2 | $10 | -$0 |
| Pre-Tax Income | -$109 | -$96 | -$57 | -$94 |
| Tax Expense | $0 | $0 | $0 | -$1 |
| Net Income | -$109 | -$96 | -$57 | -$93 |
| % Margin | – | – | – | – |
| EPS | -1.54 | -2.44 | -1.53 | -3.4 |
| % Growth | 36.9% | -59.5% | 55% | – |
| EPS Diluted | -0.15 | -2.44 | -1.53 | -3.4 |
| Weighted Avg Shares Out | 70 | 39 | 31 | 27 |
| Weighted Avg Shares Out Dil | 705 | 39 | 31 | 27 |
| Supplemental Information | – | – | – | – |
| Interest Income | $12 | $6 | $1 | $0 |
| Interest Expense | $2 | $1 | $1 | $0 |
| Depreciation & Amortization | $1 | $3 | $3 | $3 |
| EBITDA | -$106 | -$93 | -$63 | -$91 |
| % Margin | – | – | – | – |